Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: Correlations with indexes of disease activity and severity, disability, and depressive symptoms

Clinical Rheumatology

Volumn 24, Issue 1, 2005, Pages 48-54

  Danieli, Elisabetta ^a   Airò, Paolo ^a   Bettoni, Lorenzo ^a   Cinquini, Massimo ^a   Antonioli, Chiara M ^a   Cavazzana, Ilaria ^a   Franceschini, Franco ^a   Cattaneo, Roberto ^a  

^a Spedali Civili ^*  (Italy)

Author keywords

Depression; Disease activity; Disease severity; HAQ; SF 36; Systemic sclerosis

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; ILOPROST; INFLIXIMAB; METHOTREXATE; PENICILLAMINE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HEART DISEASE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN; PERCEPTION; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SHORT FORM 36; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

AGED; DEPRESSION; DISABILITY EVALUATION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TRANSLATIONS;

EID: 13444292536     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0970-z     Document Type: Article

References (36)

1. Haythornthwaite JA, Heinberg LJ, McGuire L (2003) Psychological factors in scleroderma. Rheum Dis Clin North Am 29:427-439 12841303
2. Calkins DR, Rubenstein LV, Cleary PD, et al. (1991) Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med 114:451-454 1:STN:280:By6C3sngsV0%3D
3. Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 30:473-483 1593914
4. Brazier JE, Harper R, Jones MB, et al. (1992) Validating the SF-36 health survey questionnaire: New outcome measure for primary care. BMJ 305:160-164 1:STN:280:By2A1cnhtlw%3D
5. Mc Horney CA, Ware JE, Lu JFR (1994) The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 32:40-66 1:STN:280:ByuC3cvjs1M%3D
6. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russel IT (1993) The SF-36 Health Survey questionnaire: An outcome measure suitable for routine use within the NHS? BMJ 306:1440-1444 1:STN:280:ByyB1Mbit1I%3D
7. Talamo J, Frater A, Gallivan S, Young A (1997) Use of the short-form (SF-36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 36:463-469 10.1093/rheumatology/36.4.463
8. Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511-517 1:STN:280:ByiB3M7mvFU%3D
9. DaCosta D, Dobkin PL, Fitzcharles MA, et al. (2000) Determinants of health status in fibromyalgia: A comparative study with systemic lupus erythematosus. J Rheumatol 27:365-372 1:STN:280:DC%2BD3c7kvVagtg%3D%3D
10. Ruta DA, Hursat MP, Kind P, Hunter M, Shibbings A (1998) Measuring health status in British patients with rheumatoid arthritis: Reliability, validity and responsiveness of the Short-Form 36-item health survey (SF-36). Br J Rheumatol 37:425-436 10.1093/rheumatology/37.4.425
11. Kvien TK, Kaasa S, Smedstad LM (1998) Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 51:10771086 10.1016/S0895-4356(98)00099-7
12. Hill CL, Parsons J, Taylor A, Leach G (1999) Health related quality of life in a population sample with arthritis. J Rheumatol 26:2029-2035 1:STN:280:DyaK1MvitFCgsg%3D%3D
13. Strombeck B, Ekdahl C, Manthorpe R, Wilkstrom I, Jacibsson L (2000) Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 29:20-28 10.1080/030097400750001761
14. Husted JA, Gladman DD, Farewell VT, Cook RJ (2001) Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis. Arthritis Rheum 45:151-158 10.1002/1529-0131(200104)45:2<151::AID-ANR168>3.3.CO;2-K
15. Wiles NJ, Scott DGI, Barrett EM, et al. (2001) Benchmarking: The five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire: And the short-form (SF-36) in a community and a clinic based sample. Ann Rheum Dis 60:956-961 10.1136/ard.60.10.956
16. Suarez-Alzamor ME, Ahn C, Friedman AW, et al. (2000) Performance of outcome measures in systemic sclerosis (abstract). Arthritis Rheum 43:S319
17. Grove ML, Wilson A, Raza K, Carruthers DM, Bacon P (2000) Patients with damage from primary systemic vasculitides experience impaired physical health as measured by the SF-36 (abstract). Arthritis Rheum 43:S368
18. Cossutta R, Zeni S, Soldi A, Colombelli P, Belotti Masserini A, Fantini F (2002) Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire (in Italian). Reumatismo 54:122-127 1:STN:280:DC%2BD38zmtVyhtQ%3D%3D
19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581-590 7378088
20. Arnett FC, Edworthy SM, Block DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324 1:STN:280:BieC1M3nt1Q%3D
21. LeRoy EC, Black C, Fleischmayer R, et al. (1988) Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15:202-208 1:STN:280:BieB3c%2FhsVQ%3D
22. Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: Translation, validation and norming. J Clin Epidemiol 51:1025-1036 10.1016/S0895-4356(98)00094-8
23. Steen VD, Mesdger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scale to demonstrate change in systemic sclerosis over time. Arthritis Rheum 40:1984-1991 1:STN:280:DyaK1c%2FjtVeluw%3D%3D
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53-63
25. Mesdger TA Jr, Silman AJ, Steen VD, et al. (1999) A disease severity scale for systemic sclerosis: Development and testing. J Rheumatol 26:2159-2167 10529133
26. Valentini G, Della Rossa A, Bombardieri S, et al. (2001) European multicentre study to define activity criteria for systemic sclerosis. II Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592-598 10.1136/ard.60.6.592
27. van der Heijde DM, van't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van LeeuwenMA, et al. (1990) Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score. Ann Rheum Dis 49:916-920 2256738
28. Bettoni L, Geri P, Airò P, et al. (2002) Systemic sclerosis therapy with Iloprost. A prospective observational study of 30 patients treated for a median of 3 years. Clin Rheumatol 21:244-250 1:STN:280:DC%2BD38zms1eitg%3D%3D
29. Merkel PA, Herlyn K, Martin RW, et al. (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 46:2410-2420 10.1002/art.10486
30. Clements PJ, Wong WK, Hurwitz EL, et al. (1999) Correlates of the Disability Index of the Health Assessment Questionnaire: A measure of functional impairment in systemic sclerosis. Arthritis Rheum 42:2372-2380 10.1002/1529-0131(199911)42:11<2372::AID-ANR16>3.0.CO;2-J
31. Clements PJ, Wong WK, Hurwitz EL, et al. (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44:653-661 10.1002/1529-0131(200103)44:3<653::AID-ANR114>3.3.CO;2-H
32. Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 39:1035-1040 1:STN:280:BymB3s3ktlI%3D
33. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, et al. (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267-275 10.1016/S0304-3959(01)00409-2
34. Newman S, Mulligan K (2000) The psychology of rheumatic diseases. Baillieres Clin Rheumatol 14:773-786 10.1053/berh.2000.0112
35. Moser DK, Clements PJ, Brecht ML, Weiner SR (1993) Predictors of psychosocial adjustment in systemic sclerosis. The influence of formal education level, functional ability, hardness, uncertainty, and social support. Arthritis Rheum 36:1398-1405 1:STN:280:ByuD3s%2FhtFE%3D
36. Benrud-Larson LM, Heinberg LJ, Haythornthwaite JA, et al. (2002) Body image dissatisfaction in scleroderma: Extent and relationship to psychosocial function. Health Psychol 22:130-139 10.1037//0278-6133.22.2.130